Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Liver Diseases

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 46 articles: HTML format Text format

Single Articles

January 2012
1. 
   Correction: Sirtuin 1 Is Upregulated in a Subset of Hepatocellular Carcinomas where It Is Essential for Telomere Maintenance and Tumor Cell Growth.
   Cancer Res. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
2. O'DELL MR , Huang JL, Whitney-Miller CL, Deshpande V, et al
   KrasG12D and p53 mutation cause primary intra-hepatic cholangiocarcinoma.
   Cancer Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
3. BHALLA K , Hwang BJ, Dewi RE, Ou L, et al
   PGC1alpha promotes tumor growth by inducing gene expression programs supporting lipogenesis.
   Cancer Res. 2011;71:6888-98.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. LIU F , Liu Q, Yang D, Bollag WB, et al
   Verticillin A overcomes apoptosis resistance in human colon carcinoma through DNA methylation-dependent upregulation of BNIP3.
   Cancer Res. 2011;71:6807-16.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
5. XIE R , Wang F, McKeehan WL, Liu L, et al
   Autophagy Enhanced by Microtubule and Mitochondrion-associated MAP1S Suppresses Genome Instability and Hepatocarcinogenesis.
   Cancer Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. PARK JK , Kogure T, Nuovo GJ, Jiang J, et al
   miR-221 silencing blocks hepatocellular carcinoma and promotes survival.
   Cancer Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. SASAKI Y , Negishi H, Idogawa M, Yokota I, et al
   p53 negatively regulates the hepatoma growth factor HDGF.
   Cancer Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. UENO S , Mojic M, Ohashi Y, Higashi N, et al
   Asialoglycoprotein receptor promotes cancer metastasis by activating the EGFR-ERK pathway.
   Cancer Res. 2011;71:6419-27.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. KOGO R , Shimamura T, Mimori K, Kawahara K, et al
   Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers.
   Cancer Res. 2011;71:6320-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. WU YM , Liu CH, Hu RH, Huang MJ, et al
    Mucin glycosylating enzyme GALNT2 promotes the malignant character of hepatocellular carcinoma by modifying the EGF receptor.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
11. LEE EK , Kim DG, Kim JS, Yoon Y, et al
    Cell cycle regulator Cks1 promotes hepatocellular carcinoma by supporting NF-{kappa}B-dependent expression of interleukin-8.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. PATTERSON AD , Maurhofer O, Beyoglu D, Lanz C, et al
    Aberrant Lipid Metabolism in Hepatocellular Carcinoma Revealed by Plasma Metabolomics and Lipid Profiling.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. STEFANSKA B , Huang J, Bhattacharyya B, Suderman M, et al
    Definition of the landscape of promoter DNA hypomethylation in liver cancer.
    Cancer Res. 2011;71:5891-903.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
14. HALAMA N , Michel S, Kloor M, Zoernig I, et al
    Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
15. SAEZ-RODRIGUEZ J , Alexopoulos L, Zhang M, Morris MK, et al
    COMPARING SIGNALING NETWORKS BETWEEN NORMAL AND TRANSFORMED HEPATOCYTES USING DISCRETE LOGICAL MODELS.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
16. SONG J , Lei F, Zhao B, Haque R, et al
    In vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. REN N , Wu JC, Dong QZ, Sun HJ, et al
    Association of Specific Genotypes in Metastatic Suppressor HTPAP with Tumor Metastasis and Clinical Prognosis in Hepatocellular Carcinoma.
    Cancer Res. 2011;71:3278-86.
    PubMed     Text format     Related articles   
    
    
    
    
18. VOISIN T , El Firar A, Fasseu M, Rouyer-Fessard C, et al
    Aberrant expression of OX1 receptors for orexins in colon cancers and liver metastases: an openable gate to apoptosis.
    Cancer Res. 2011;71:3341-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
19. CHEN J , Zhang B, Wong N, Lo AW, et al
    Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth.
    Cancer Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
20. LUTH S , Schrader J, Zander S, Carambia A, et al
    Chronic inflammatory interferon{gamma}-signaling suppresses hepatocarcinogenesis in mice by sensitizing hepatocytes for apoptosis.
    Cancer Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
21. CHENG AS , Lau SS, Chen Y, Kondo Y, et al
    EZH2-mediated concordant repression of Wnt antagonists promotes {beta}-catenin-dependent hepatocarcinogenesis.
    Cancer Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
22. ARZUMANYAN A , Friedman T, Ng IO, Clayton M, et al
    Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells?
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. STAUFFER JK , Scarzello AJ, Andersen JB, De Kluyver RL, et al
    Coactivation of AKT and beta-catenin in mice rapidly induces formation of lipogenic liver tumors.
    Cancer Res. 2011;71:2718-27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
24. MAK GW , Chan MM, Leong VY, Lee JM, et al
    Overexpression of a novel activator of PAK4, the CDK5 kinase associated protein CDK5RAP3, promotes hepatocellular carcinoma metastasis.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. CHEN Y , Wang D, Guo Z, Zhao J, et al
    Rho Kinase Phosphorylation Promotes Ezrin-Mediated Metastasis in Hepatocellular Carcinoma.
    Cancer Res. 2011;71:1721-1729.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. HSU RY , Chan CH, Spicer JD, Rousseau MC, et al
    LPS-Induced TLR4 Signaling in Human Colorectal Cancer Cells Increases {beta}1 Integrin-Mediated Cell Adhesion and Liver Metastasis.
    Cancer Res. 2011;71:1989-98.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
27. GARCIA A , Zeng Y, Muthupalani S, Ge Z, et al
    H. hepaticus-induced liver tumor promotion is associated with increased serum bile acid and a persistent microbial induced immune response.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. LI XJ , Ong CK, Cao Y, Xiang Y, et al
    Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
29. CAO Z , Fan-Minogue H, Bellovin DI, Yevtodiyenko A, et al
    MYC Phosphorylation, Activation, and Tumorigenic Potential in Hepatocellular Carcinoma are Regulated by HMG-CoA Reductase.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
30. MAJUMDER S , Roy S, Kaffenberger T, Wang B, et al
    Loss of Metallothionein Predisposes Mice to Diethylnitrosamine-Induced Hepatocarcinogenesis by Activating NF-{kappa}B Target Genes.
    Cancer Res. 2010;70:10265-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. ROESSLER S , Jia HL, Budhu A, Forgues M, et al
    A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients.
    Cancer Res. 2010;70:10202-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. MALDONADO EN , Patnaik J, Mullins MR, Lemasters JJ, et al
    Free tubulin modulates mitochondrial membrane potential in cancer cells.
    Cancer Res. 2010;70:10192-201.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. LAURENT C , Valet F, Planque N, Silveri L, et al
    HIGH PTP4A3 PHOSPHATASE EXPRESSION CORRELATES WITH METASTATIC RISK IN UVEAL MELANOMA PATIENTS.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
34. LI LM , Hu ZB, Zhou ZX, Chen X, et al
    Serum microRNA Profiles Serve as Novel Biomarkers for HBV Infection and Diagnosis of HBV-Positive Hepatocarcinoma.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. DARSIGNY M , Babeu JP, Seidman EG, Gendron FP, et al
    Hepatocyte Nuclear Factor-4{alpha} Promotes Gut Neoplasia in Mice and Protects against the Production of Reactive Oxygen Species.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. OU DL , Shen YC, Yu SL, Chen KF, et al
    Induction of DNA Damage-Inducible Gene GADD45{beta} Contributes to Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Cells.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. LEE YJ , Karl DL, Maduekwe UN, Rothrock C, et al
    Differential effects of VEGFR-1 and VEGFR-2 inhibition on tumor metastases based on host organ environment.
    Cancer Res. 2010;70:8357-67.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
38. KONG KL , Kwong DL, Fu L, Chan TH, et al
    Characterization of a Candidate Tumor Suppressor Gene Uroplakin 1A in Esophageal Squamous Cell Carcinoma.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. LEE YH , Andersen JB, Song HT, Judge AD, et al
    Definition of Ubiquitination Modulator COP1 as a Novel Therapeutic Target in Human Hepatocellular Carcinoma.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. JIANG H , Martin V, Gomez-Manzano C, Johnson DG, et al
    The RB-E2F1 pathway regulates autophagy.
    Cancer Res. 2010;70:7882-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. ELYAKIM E , Sitbon E, Faerman A, Tabak S, et al
    hsa-miR-191 Is a Candidate Oncogene Target for Hepatocellular Carcinoma Therapy.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. MUHLEBACH MD , Schaser T, Zimmermann M, Armeanu S, et al
    Liver cancer protease activity profiles support therapeutic options with matrix metalloproteinase-activatable oncolytic measles virus.
    Cancer Res. 2010;70:7620-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. BOISSAN M , De Wever O, Lizarraga F, Wendum D, et al
    Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells.
    Cancer Res. 2010;70:7710-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
44. NING BF , Ding J, Yin C, Zhong W, et al
    Hepatocyte Nuclear Factor 4{alpha} Suppresses the Development of Hepatocellular Carcinoma.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
45. LIU H , Huang D, McArthur DL, Boros LG, et al
    Fructose induces transketolase flux to promote pancreatic cancer growth.
    Cancer Res. 2010;70:6368-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
46. IIDA N , Nakamoto Y, Baba T, Nakagawa H, et al
    Antitumor Effect after Radiofrequency Ablation of Murine Hepatoma Is Augmented by an Active Variant of CC Chemokine Ligand 3/Macrophage Inflammatory Protein-1{alpha}
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: